Role Of IGF Binding Protein-3 (IGFBP-3) And IGFBP-5 As Modulators Of Nuclear Hormone Signalling
Funder
National Health and Medical Research Council
Funding Amount
$465,750.00
Summary
The insulin-like growth factors are small proteins involved in the growth of most tissues. Their actions are regulated by binding to larger proteins (known as IGFBPs) in the bloodstream and outside the cell. However, some IGFBPs are also found inside cells, where they seem to carry out other functions. We believe that two of these binding proteins, IGFBP-3 and IGFBP-5, change the way cells respond to vitamin A and vitamin D. These two vitamins are important in cell growth and in the way certain ....The insulin-like growth factors are small proteins involved in the growth of most tissues. Their actions are regulated by binding to larger proteins (known as IGFBPs) in the bloodstream and outside the cell. However, some IGFBPs are also found inside cells, where they seem to carry out other functions. We believe that two of these binding proteins, IGFBP-3 and IGFBP-5, change the way cells respond to vitamin A and vitamin D. These two vitamins are important in cell growth and in the way certain cells perform specialised functions. In test-tube experiments, IGFBP-3 and IGFBP-5 interact directly with the receptors that regulate the effects of these hormones. If the same thing happens inside the cell, IGFBP-3 and IGFBP-5 could change the way these receptors respond to signals from outside the cell. We will investigate what effect these IGFBPs have in living cells and in whole animals and how this may relate to human disease. If we are able to understand how IGFBP-3 and IGFBP-5 affect the way cells respond to vitamin A and D, then we may be able to develop new ways to treat certain human diseases.Read moreRead less
Modulating Inflammatory And Fibrogenic Pathways In Kidney Disease Using A Novel Antagonist Of Protease-Activated-Receptor-2
Funder
National Health and Medical Research Council
Funding Amount
$581,116.00
Summary
Chronic kidney disease (CKD) now affects 10% of adults in industrialised countries. Current treatments are largely ineffective. Thus developing better CKD treatments will have substantial public health benefit. Three well established and clinically relevant animal models of kidney disease will be used to test the ability of a new experimental anti-inflammatory drug, developed by members of this research team at The University of Queensland, to prevent or lessen the progression of CKD.
Cellular Regulation Of Receptor Signalling And Cytokine Responses
Funder
National Health and Medical Research Council
Funding Amount
$859,288.00
Summary
Cell surface receptors and signalling pathways elicit the release of cytokines, or chemical messengers, to control inflammation, which is the body’s response to infection or danger. We have discovered a new signalling pathway that can turn off inflammation and help prevent inflammatory disease. Our studies will now define the molecular details of this pathway and show how new and existing drugs targeting this pathway can be optimally used to treat inflammation and cancer.
Industrial Transformation Training Centres - Grant ID: IC230100036
Funder
Australian Research Council
Funding Amount
$4,999,600.00
Summary
ARC Training Centre for Radiation Innovation. This Centre aims to train the next generation of transdisciplinary leaders to enable, grow and transform industries that utilise or are impacted by radiation. Rapid growth in the natural resources, health, space and national security sectors urgently requires a highly capable workforce with scientific and regulatory knowledge to develop new technologies and social licence needs to maximise benefits. Outcomes include new methods of radiopharmaceutical ....ARC Training Centre for Radiation Innovation. This Centre aims to train the next generation of transdisciplinary leaders to enable, grow and transform industries that utilise or are impacted by radiation. Rapid growth in the natural resources, health, space and national security sectors urgently requires a highly capable workforce with scientific and regulatory knowledge to develop new technologies and social licence needs to maximise benefits. Outcomes include new methods of radiopharmaceutical production, more resilient spacecraft and robust regulatory frameworks. Industries and communities will benefit from a future workforce prepared for safe adoption, development and delivery of emerging techniques and advanced radiation technologies, enhancing Australia’s prosperity and security.Read moreRead less
Low-energy electron transport in soft-condensed biological matter. To obtain optimal accuracy and selectivity of ionising radiation based technologies requires an understanding and quantification of the underpinning fundamental physical processes. This project will focus on developing accurate theoretical models of low-energy electron transport in biological matter which account for new physical mechanisms.
Nanostructure engineered low activation superconductors for fusion energy. This project aims to develop a novel, low activation and liquid helium-free superconducting solution with superior electromagnetic, mechanical and thermal properties for use in fusion reactors. Superconducting magnets and their associated cryogenic cooling systems represent a key determinant of thermal efficiency and the construction/operating costs of fusion reactors. The project expects to overcome these barriers so tha ....Nanostructure engineered low activation superconductors for fusion energy. This project aims to develop a novel, low activation and liquid helium-free superconducting solution with superior electromagnetic, mechanical and thermal properties for use in fusion reactors. Superconducting magnets and their associated cryogenic cooling systems represent a key determinant of thermal efficiency and the construction/operating costs of fusion reactors. The project expects to overcome these barriers so that widespread uptake of these reactors becomes viable. Outcomes from the project will include a fundamental understanding of pure and doping-induced isotopic magnesium diboride superconductors and their behaviour under high neutron flux and harsh plasma atmosphere, which are specifically designed for application in next-generation, low-cost fusion reactors.Read moreRead less
Novel collision experiments with metastable neon atoms in an atom trap. The aim of this project is to investigate collisions involving atoms in long lived excited states (metastable states). The project will utilise a magneto-optical trap to investigate electron-atom collisions as well as interatomic collisions for ultra-cold atoms. The outcomes of such investigations extend scientific knowledge of these important processes as a well as provide data for testing fundamental scattering theories. T ....Novel collision experiments with metastable neon atoms in an atom trap. The aim of this project is to investigate collisions involving atoms in long lived excited states (metastable states). The project will utilise a magneto-optical trap to investigate electron-atom collisions as well as interatomic collisions for ultra-cold atoms. The outcomes of such investigations extend scientific knowledge of these important processes as a well as provide data for testing fundamental scattering theories. This scientific knowledge may lead to further technological advances such as more efficient light sources or a metastable-atom laser that could be used for the production of nano-scale electric circuits.Read moreRead less